HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nucleic acid amplification technique for detection of Chlamydia trachomatis infection from clinical urogenital swabs.

Abstract
An improved nucleic acid amplification test (NAAT) to detect Chlamydia trachomatis infections, based on PCR amplification within its cryptic plasmid (CT1/CT2 Test) was developed. DNA was extracted from urogenital swabs and a 594-bp long DNA fragment from the cryptic plasmid (pCT) was amplified. The sensitivity and specificity of the CT1/CT2 Test were determined to be 100 and 99%, respectively, when directly compared with current amplification kit for sexually transmitted diseases (MPCR). Basic epidemiological data related to the patients attending gynecological and/or urological clinics are also provided. The overall prevalence rate in this group of patients suspected for C. trachomatis infection was determined to be about 95 per 1000 (88 and 107 per 1000 in females and males, respectively). It demonstrates that the CT1/CT2 Test is suitable for epidemiological screening and/or diagnostic practice.
AuthorsE Biros, J Bodnár, I Biros, E Birosová, J Mojzis, M Hrivnák, L Klimcáková, I Findlay, A Mirossay, L Mirossay
JournalFolia microbiologica (Folia Microbiol (Praha)) Vol. 52 Issue 4 Pg. 437-42 ( 2007) ISSN: 0015-5632 [Print] United States
PMID18062194 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Bacterial
Topics
  • Adolescent
  • Adult
  • Aged
  • Chlamydia Infections (diagnosis, epidemiology, microbiology)
  • Chlamydia trachomatis (genetics, isolation & purification)
  • DNA, Bacterial (chemistry, genetics)
  • Female
  • Female Urogenital Diseases (diagnosis, epidemiology, microbiology)
  • Humans
  • Male
  • Male Urogenital Diseases (diagnosis, epidemiology, microbiology)
  • Middle Aged
  • Plasmids (chemistry, genetics)
  • Polymerase Chain Reaction (methods)
  • Sensitivity and Specificity
  • Sequence Analysis, DNA
  • Slovakia (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: